Dual intracellular signaling pathways mediated by the human cannabinoid CB1 receptor.

[1]  K. Waku,et al.  Evidence That the Cannabinoid CB1 Receptor Is a 2-Arachidonoylglycerol Receptor , 1999, The Journal of Biological Chemistry.

[2]  G. Martin,et al.  Dual activation and inhibition of adenylyl cyclase by cannabinoid receptor agonists: evidence for agonist-specific trafficking of intracellular responses. , 1998, The Journal of pharmacology and experimental therapeutics.

[3]  K. Catt,et al.  Mediation of Cyclic AMP Signaling by the First Intracellular Loop of the Gonadotropin-releasing Hormone Receptor* , 1998, The Journal of Biological Chemistry.

[4]  Z. Vogel,et al.  Cannabinoid Receptor Activation Differentially Regulates the Various Adenylyl Cyclase Isozymes , 1998, Journal of neurochemistry.

[5]  M. Lokhandwala,et al.  Angiotensin II AT1 receptor/signaling mechanisms in the biphasic effect of the peptide on proximal tubular Na+,K+-ATPase. , 1998, Clinical and experimental hypertension.

[6]  A. Howlett,et al.  Characterization of CB1 cannabinoid receptors using receptor peptide fragments and site-directed antibodies. , 1998, Molecular pharmacology.

[7]  P. Casellas,et al.  SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor. , 1998, The Journal of pharmacology and experimental therapeutics.

[8]  K. Mackie,et al.  LY320135, a novel cannabinoid CB1 receptor antagonist, unmasks coupling of the CB1 receptor to stimulation of cAMP accumulation. , 1998, The Journal of pharmacology and experimental therapeutics.

[9]  Robert J. Lefkowitz,et al.  Switching of the coupling of the β2-adrenergic receptor to different G proteins by protein kinase A , 1997, Nature.

[10]  I. Yamamoto,et al.  Is the cannabinoid CB1 receptor a 2-arachidonoylglycerol receptor? Structural requirements for triggering a Ca2+ transient in NG108-15 cells. , 1997, Journal of biochemistry.

[11]  P. Casellas,et al.  A Selective Inverse Agonist for Central Cannabinoid Receptor Inhibits Mitogen-activated Protein Kinase Activation Stimulated by Insulin or Insulin-like Growth Factor 1 , 1997, The Journal of Biological Chemistry.

[12]  M. Glass,et al.  Concurrent Stimulation of Cannabinoid Cb1 and Dopamine D2 Receptors Augments Camp Accumulation in Striatal Neurons: Evidence for a G S Linkage to the Cb1 Receptor , 1997 .

[13]  J. Brotchie,et al.  Paradoxical action of the cannabinoid WIN 55,212‐2 in stimulated and basal cyclic AMP accumulation in rat globus pallidus slices , 1997, British journal of pharmacology.

[14]  G. Schultz,et al.  Multiple G-protein coupling of the dog thyrotropin receptor , 1997, Molecular and Cellular Endocrinology.

[15]  R. Pertwee.  Pharmacology of cannabinoid CB1 and CB2 receptors. , 1997, Pharmacology & therapeutics.

[16]  A. Yamashita,et al.  2-Arachidonoylglycerol, a putative endogenous cannabinoid receptor ligand, induces rapid, transient elevation of intracellular free Ca2+ in neuroblastoma x glioma hybrid NG108-15 cells. , 1996, Biochemical and biophysical research communications.

[17]  D. R. Compton,et al.  Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands. , 1996, The Journal of pharmacology and experimental therapeutics.

[18]  I. Matsuoka,et al.  Identification and Characterization of a Widely Expressed Form of Adenylyl Cyclase* , 1996, The Journal of Biological Chemistry.

[19]  P. Ferrara,et al.  Molecular cloning, expression and function of the murine CB2 peripheral cannabinoid receptor. , 1996, Biochimica et biophysica acta.

[20]  P. Casellas,et al.  Signaling pathway associated with stimulation of CB2 peripheral cannabinoid receptor. Involvement of both mitogen-activated protein kinase and induction of Krox-24 expression. , 1996, European journal of biochemistry.

[21]  Pascual Ferrara,et al.  Structural Features of the Central Cannabinoid CB1 Receptor Involved in the Binding of the Specific CB1 Antagonist SR 141716A (*) , 1996, The Journal of Biological Chemistry.

[22]  B. Martin,et al.  Cannabinoid receptor down-regulation without alteration of the inhibitory effect of CP 55,940 on adenylyl cyclase in the cerebellum of CP 55,940-tolerant mice , 1996, Brain Research.

[23]  P. Casellas,et al.  Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1. , 1995, The Biochemical journal.

[24]  Z. Vogel,et al.  The peripheral cannabinoid receptor: adenylate cyclase inhibition and G protein coupling , 1995, FEBS letters.

[25]  S. Liggett,et al.  Identification of a Gs coupling domain in the amino terminus of the third intracellular loop of the alpha 2A-adrenergic receptor. Evidence for distinct structural determinants that confer Gs versus Gi coupling. , 1995, The Journal of biological chemistry.

[26]  D. Selley,et al.  In vitro autoradiography of receptor-activated G proteins in rat brain by agonist-stimulated guanylyl 5'-[gamma-[35S]thio]-triphosphate binding. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Y. Sugimoto,et al.  Selective Coupling of Prostaglandin E Receptor EP3D to Gi and Gs through Interaction of α-Carboxylic Acid of Agonist and Arginine Residue of Seventh Transmembrane Domain (*) , 1995, The Journal of Biological Chemistry.

[28]  Z. Vogel,et al.  Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. , 1995, Biochemical pharmacology.

[29]  P. Casellas,et al.  Stimulation of Cannabinoid Receptor CB1 Induces krox-24 Expression in Human Astrocytoma Cells (*) , 1995, The Journal of Biological Chemistry.

[30]  G. Chaudhuri,et al.  Cloning and sequencing of a cDNA encoding the mouse brain-type cannabinoid receptor protein. , 1995, DNA sequence : the journal of DNA sequencing and mapping.

[31]  B. Miloux,et al.  Rapid isolation of highly productive recombinant Chinese hamster ovary cell lines. , 1994, Gene.

[32]  P. Soubrié,et al.  SR141716A, a potent and selective antagonist of the brain cannabinoid receptor , 1994, FEBS letters.

[33]  S. Childers,et al.  Differential Requirements of Sodium for Coupling of Cannabinoid Receptors to Adenylyl Cyclase in Rat Brain Membranes , 1994, Journal of neurochemistry.

[34]  B. Conklin,et al.  Coupling of the alpha 2A-adrenergic receptor to multiple G-proteins. A simple approach for estimating receptor-G-protein coupling efficiency in a transient expression system. , 1994, The Journal of biological chemistry.

[35]  S. Childers,et al.  Effects of anandamide on cannabinoid receptors in rat brain membranes. , 1994, Biochemical pharmacology.

[36]  D. Storm,et al.  A novel mechanism for coupling of m4 muscarinic acetylcholine receptors to calmodulin-sensitive adenylyl cyclases: crossover from G protein-coupled inhibition to stimulation. , 1994, Biochemistry.

[37]  P. Sassone-Corsi,et al.  Multiple and cooperative phosphorylation events regulate the CREM activator function. , 1993, The EMBO journal.

[38]  S. Munro,et al.  Molecular characterization of a peripheral receptor for cannabinoids , 1993, Nature.

[39]  K. Mackie,et al.  Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[40]  P Ramond,et al.  Molecular cloning of the MCP-3 chemokine gene and regulation of its expression. , 1993, European cytokine network.

[41]  C. Stratowa,et al.  Functional testing of human dopamine D1 and D5 receptors expressed in stable cAMP-responsive luciferase reporter cell lines. , 1993, Journal of receptor research.

[42]  D. Gibson,et al.  Isolation and structure of a brain constituent that binds to the cannabinoid receptor. , 1992, Science.

[43]  L. Matsuda,et al.  Cannabinoid agonists stimulate both receptor- and non-receptor-mediated signal transduction pathways in cells transfected with and expressing cannabinoid receptor clones. , 1992, Molecular pharmacology.

[44]  S. Liggett,et al.  Simultaneous coupling of alpha 2-adrenergic receptors to two G-proteins with opposing effects. Subtype-selective coupling of alpha 2C10, alpha 2C4, and alpha 2C2 adrenergic receptors to Gi and Gs. , 1992, The Journal of biological chemistry.

[45]  I. Nishimoto,et al.  Detection of G protein-activator regions in M4 subtype muscarinic, cholinergic, and alpha 2-adrenergic receptors based upon characteristics in primary structure. , 1992, The Journal of biological chemistry.

[46]  A. Gilman,et al.  Type-specific regulation of adenylyl cyclase by G protein beta gamma subunits. , 1991, Science.

[47]  G Vassart,et al.  Molecular cloning of a human cannabinoid receptor which is also expressed in testis. , 1991, The Biochemical journal.

[48]  M. Reichman,et al.  Delta 9-tetrahydrocannabinol inhibits arachidonic acid acylation of phospholipids and triacylglycerols in guinea pig cerebral cortex slices. , 1991, Molecular pharmacology.

[49]  H. Bourne,et al.  Mutant α subunits of Gi2 inhibit cyclic AMP accumulation , 1991, Nature.

[50]  T. Bonner,et al.  Structure of a cannabinoid receptor and functional expression of the cloned cDNA , 1990, Nature.

[51]  J. Venter,et al.  Cloning, sequence analysis, and permanent expression of a human alpha 2-adrenergic receptor in Chinese hamster ovary cells. Evidence for independent pathways of receptor coupling to adenylate cyclase attenuation and activation. , 1989, The Journal of biological chemistry.

[52]  R. Pertwee.  The central neuropharmacology of psychotropic cannabinoids. , 1988, Pharmacology & therapeutics.